about
Epidemiology of age-related macular degeneration (AMD): associations with cardiovascular disease phenotypes and lipid factors.New milestones ahead in complement-targeted therapy.New therapeutic and diagnostic opportunities for injured tissue-specific targeting of complement inhibitors and imaging modalities.Gene Transfer of Prolyl Hydroxylase Domain 2 Inhibits Hypoxia-inducible Angiogenesis in a Model of Choroidal NeovascularizationA Revised Hemodynamic Theory of Age-Related Macular Degeneration.Complement in removal of the dead - balancing inflammation.The Age-Related Eye Disease 2 Study: Micronutrients in the Treatment of Macular Degeneration.Can innate and autoimmune reactivity forecast early and advance stages of age-related macular degeneration?Recent advances in the management and understanding of macular degeneration.The Evolving Landscape for Complement Therapeutics in Rheumatic and Autoimmune Diseases.Efficacy of a Fatty Acids Dietary Supplement in a Polyethylene Glycol-Induced Mouse Model of Retinal Degeneration.Novel mechanisms and functions of complement.A model to study complement involvement in experimental retinal degeneration.Uncovering genetic and non-genetic biomarkers specific for exudative age-related macular degeneration: significant association of twelve variants.Thermal Stimulation of the Retina Reduces Bruch's Membrane Thickness in Age Related Macular Degeneration Mouse Models.
P2860
Q30239897-0D4D765C-5FE6-4DAD-A7C3-A598E4286471Q33602320-A4C2CD76-472B-4742-A89D-A25D5609A94FQ37180522-61C85B1C-69EC-4C6C-8ED4-64C7BEC70190Q37635057-E1CC98D9-4F67-47CE-9537-DD10DD9712ADQ38898742-169CB81D-482A-41E9-9ABE-F19AAF250038Q38991044-22BB760F-29A9-46C1-A422-CE2A76D50709Q39092535-529FD932-B68E-4F62-A3A3-A9943DA33D65Q39110045-6B45F1ED-72E8-45C7-93DF-2E8B521C25E1Q39297094-ABF07137-3F91-4A02-A0FD-0867844B9827Q39450682-1DD2DB06-7257-4FF4-B35E-7613E09788A1Q47124297-C6FBE66E-BEEA-437E-8075-EB85C28AACE6Q47396517-60EAA9ED-C23A-4A7B-8B72-D61C5F52ECA3Q50046723-3D29B1D3-276D-4176-ACE1-CB760F4D18CBQ54965254-E4B76CF0-54EE-4871-A927-42C7C260B3E0Q55016413-4219B095-64EB-4507-9F2B-A387986A17D7
P2860
description
2016 nî lūn-bûn
@nan
2016 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
2016 թվականի հունիսին հրատարակված գիտական հոդված
@hy
2016年の論文
@ja
2016年論文
@yue
2016年論文
@zh-hant
2016年論文
@zh-hk
2016年論文
@zh-mo
2016年論文
@zh-tw
2016年论文
@wuu
name
Age-related macular degeneration: Complement in action
@ast
Age-related macular degeneration: Complement in action
@en
Age-related macular degeneration: Complement in action
@nl
type
label
Age-related macular degeneration: Complement in action
@ast
Age-related macular degeneration: Complement in action
@en
Age-related macular degeneration: Complement in action
@nl
prefLabel
Age-related macular degeneration: Complement in action
@ast
Age-related macular degeneration: Complement in action
@en
Age-related macular degeneration: Complement in action
@nl
P1433
P1476
Age-related macular degeneration: Complement in action
@en
P2093
Brian L Yaspan
Erich C Strauss
P356
10.1016/J.IMBIO.2015.11.007
P407
P577
2016-06-01T00:00:00Z